Envoy Medical, Inc. (COCHW) stock
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Envoy Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Envoy Medical's profit margin for the twelve months ending Jun 30, 2026 was -11304.8%. For fiscal 2025 it was -9857.3%, against -9242.2% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9857.3% | −615.0 |
| FY2024 | Dec 31, 2024 | -9242.2% | +226.8 |
| FY2023 | Dec 31, 2023 | -9469.0% | −2750.4 |
| FY2022 | Dec 31, 2022 | -6718.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -11729.4% | −4434.5 |
| Q1 FY2026 | Mar 31, 2026 | -11156.4% | −291.2 |
| Q4 FY2025 | Dec 31, 2025 | -8781.3% | +2213.9 |
| Q3 FY2025 | Sep 30, 2025 | -15433.3% | −4790.5 |
| Q2 FY2025 | Jun 30, 2025 | -7294.9% | −1490.5 |
| Q1 FY2025 | Mar 31, 2025 | -10865.2% | −238.1 |
| Q4 FY2024 | Dec 31, 2024 | -10995.2% | −5842.6 |
| Q3 FY2024 | Sep 30, 2024 | -10642.9% | −12596.6 |
| Q2 FY2024 | Jun 30, 2024 | -5804.4% | +15365.4 |
| Q1 FY2024 | Mar 31, 2024 | -10627.1% | +6363.9 |
| Q4 FY2023 | Dec 31, 2023 | -5152.6% | +52232.4 |
| Q3 FY2023 | Sep 30, 2023 | 1953.8% | +4302.9 |
| Q2 FY2023 | Jun 30, 2023 | -21169.8% | – |
| Q1 FY2023 | Mar 31, 2023 | -16991.0% | – |
| Q4 FY2022 | Dec 31, 2022 | -57385.0% | – |
| Q3 FY2022 | Sep 30, 2022 | -2349.1% | – |